Abstract
This study investigates the immunogenicity of extended mRNA vaccine dosing intervals.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
2019-nCoV Vaccine mRNA-1273 / administration & dosage*
-
2019-nCoV Vaccine mRNA-1273 / immunology*
-
Adult
-
Allied Health Personnel
-
Angiotensin-Converting Enzyme 2 / immunology
-
Antibodies, Neutralizing / blood
-
BNT162 Vaccine / administration & dosage*
-
BNT162 Vaccine / immunology*
-
Canada
-
Female
-
Humans
-
Immunization Schedule*
-
Immunoglobulin G / blood
-
Male
-
SARS-CoV-2 / immunology*
-
Spike Glycoprotein, Coronavirus / immunology
Substances
-
Antibodies, Neutralizing
-
Immunoglobulin G
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2
-
2019-nCoV Vaccine mRNA-1273
-
BNT162 Vaccine